Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Bictegravir/emtricitabine/tenofovir alafenamide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Biktarvy 50mg/200mg/25mg tablets
0503010AQBBAAAA
|
Biktarvy | Bictegravir/emtricitabine/tenofovir alafenamide | Infections | 10 |
|
Bictegravir 50mg /Emtr 200mg /Tenofovir alafenamide 25mg tab
0503010AQAAAAAA
|
Bictegravir/emtricitabine/tenofovir alafenamide | Bictegravir/emtricitabine/tenofovir alafenamide | Infections | 2 |
|
Biktarvy 30mg/120mg/15mg tablets
0503010AQBBABAB
|
Biktarvy | Bictegravir/emtricitabine/tenofovir alafenamide | Infections | 1 |
|
Bictegravir 30mg /Emtr 120mg /Tenofovir alafenamide 15mg tab
0503010AQAAABAB
|
Bictegravir/emtricitabine/tenofovir alafenamide | Bictegravir/emtricitabine/tenofovir alafenamide | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.